Celldex Therapeutics
CLDX
#4701
Rank
S$2.53 B
Marketcap
S$38.16
Share price
-0.51%
Change (1 day)
9.41%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -S$0.34 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are S$2.6 Million. In 2024 the company made an earning of -S$0.26 Billion a decrease over its 2023 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.34 Billion33.13%
2024 -S$0.26 Billion37.34%
2023 -S$0.19 Billion32.63%
2022 -S$0.14 Billion54.88%
2021 -S$89.61 Million39.49%
2020 -S$64.25 Million-9.08%
2019 -S$70.66 Million-28.64%
2018 -S$99.02 Million-30.11%
2017 -S$0.15 Billion-17.75%
2016 -S$0.18 Billion4.5%
2015 -S$0.17 Billion4.09%
2014 -S$0.16 Billion51.57%
2013 -S$0.11 Billion40.1%
2012 -S$74.58 Million
2010 -S$1.62 Million-96.59%
2009 -S$47.44 Million
2006 -S$28.99 Million
2004 -S$17.61 Million15.75%
2003 -S$15.21 Million-18.69%
2002 -S$18.71 Million-41.22%
2001 -S$31.82 Million59%
2000 -S$20.01 Million27.65%
1999 -S$15.68 Million53.12%
1998 -S$10.24 Million2.6%
1997 -S$9.98 Million-33.62%
1996 -S$15.04 Million-1.69%
1995 -S$15.3 Million22.92%
1994 -S$12.45 Million-0%
1993 -S$12.45 Million
1991 -S$7.65 Million90.32%
1990 -S$4.02 Million10.71%
1989 -S$3.63 Million833.33%
1988 -S$0.39 Million-400%
1987 S$0.12 M-125%
1986 -S$0.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-S$1.03 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.77 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.68 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.35 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$12.08 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-S$3.64 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA